Simplex Trading
URGN icon

Simplex Trading’s UroGen Pharma URGN Stock Holding History

Simplex Trading’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$333K Sell
18,500
-40,900
-69% -$820K ﹤0.01% 3708
2025
Q4 		$1.39M Buy
59,400
+10,100
+20% +$219K ﹤0.01% 2291
2025
Q3 		$983K Sell
49,300
-147,100
-75% -$2.64M ﹤0.01% 3061
2025
Q2 		$2.69M Buy
196,400
+193,800
+7,454% +$1.86M ﹤0.01% 1854
2025
Q1 		$28K Buy
2,600
+2,100
+420% +$22.4K ﹤0.01% 6317
2024
Q4 		$5K Sell
500
-32,500
-98% -$389K ﹤0.01% 7670
2024
Q3 		$419K Sell
33,000
-30,600
-48% -$454K ﹤0.01% 3789
2024
Q2 		$1.07M Buy
63,600
+59,400
+1,414% +$845K ﹤0.01% 2852
2024
Q1 		$63K Sell
4,200
-1,300
-24% -$21.2K ﹤0.01% 6057
2023
Q4 		$82K Sell
5,500
-1,400
-20% -$18.2K ﹤0.01% 5591
2023
Q3 		$96K Buy
+6,900
New +$111K ﹤0.01% 5132
2022
Q4 		– Sell
-200
Closed -$1K – 10503
2022
Q3 		$1K Hold
200
– – ﹤0.01% 9660
2022
Q2 		$1K Sell
200
-300
-60% -$2.06K ﹤0.01% 9691
2022
Q1 		$4K Hold
500
– – ﹤0.01% 9602
2021
Q4 		$4K Buy
+500
New +$7.05K ﹤0.01% 9721
2021
Q1 		– Sell
-1
Closed -$1K – 10107
2020
Q4 		$1K Buy
+1
New +$21 ﹤0.01% 8168
2020
Q1 		– Sell
-90
Closed -$300K – 8327
2019
Q4 		$300K Sell
90
-117
-57% -$3.19K ﹤0.01% 3290
2019
Q3 		$493K Buy
+207
New +$6.77K ﹤0.01% 2647

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Simplex Trading's URGN Position: Q1 2026 in Review

Simplex Trading reduced its UroGen Pharma (URGN) stake by 64% in Q1 2026, selling an estimated $282K and leaving 8,066 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #4668.

Simplex Trading first reported a position in URGN in Q3 2019 and has held it in 22 quarters since. The position peaked at $2.53M in Q2 2025. 172 funds tracked by Wall St. Rank hold URGN as of Q1 2026.

  • Simplex Trading held 8,066 shares of UroGen Pharma worth $145K as of Q1 2026.
  • Simplex Trading sold 14,043 UroGen Pharma shares in Q1 2026, an estimated $282K.
  • UroGen Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4668 holding.
  • Simplex Trading first reported a position in UroGen Pharma in Q3 2019 and has held it in 22 quarters since.
  • Simplex Trading's UroGen Pharma position peaked at $2.53M in Q2 2025.
  • 172 funds tracked by Wall St. Rank held UroGen Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.